Bleakley Financial Group, LLC

Position in LQDA — Liquidia Corp

CIK 1936953 PARSIPPANY, NJ

Position in LQDA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$862,547

+$55,550 QoQ

Shares Held

22,855

-2.3% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bleakley Financial Group, LLC holds $14,751,437 across 10 Drug Manufacturers - Specialty & Generic names. LQDA ranks #4 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	431,602	$7,993,269
2	ZTS	Zoetis Inc.	18,748	$2,216,201
3	LNTH	Lantheus Holdings, Inc.	13,951	$1,058,183
4	LQDA	Liquidia Corp This page	22,855	$862,547
5	PBH	Prestige Consumer Healthcare Inc.	12,245	$725,761
6	AQST	Aquestive Therapeutics, Inc.	135,767	$563,433
7	HROW	Harrow, Inc.	13,183	$464,832
8	ALKS	Alkermes plc.	10,064	$355,863

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$862,547	22,855	-2.3%	Shares	Sole	2026-05-04
2025-12-31	$806,997	23,398	-4.6%	Shares	Sole	2026-02-09
2025-09-30	$557,448	24,514	-2.8%	Shares	Sole	2025-11-10
2025-06-30	$314,365	25,230	-0.3%	Shares	Sole	2025-07-30
2025-03-31	$373,293	25,308	+6.4%	Shares	Sole	2025-05-01
2024-12-31	$279,711	23,785	-7.4%	Shares	Sole	2025-01-27
2024-09-30	$256,920	25,692	-16.5%	Shares	Sole	2024-10-16
2024-06-30	$369,192	30,766	-7.5%	Shares	Sole	2024-08-12
2024-03-31	$490,437	33,250	+6.6%	Shares	Sole	2024-05-08
2023-12-31	$375,251	31,193	+45.6%	Shares	Sole	2024-01-25
2023-09-30	$135,859	21,429	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.